Pasar al contenido principal

EFICACIA DE LA REHABILITACION FUNCIONAL ADAPTADA A PACIENTES CON PRIMEROS EPISODIOS PSICOTICOS COADYUVANTE AL TRATAMIENTO FARMACOLOGICO VERSUS TRATAMIENTO FARMACOLOGICO HABITUAL (FROZEN)

PI18/00789

•
Nombre agencia financiadora Instituto de Salud Carlos III
Acrónimo agencia financiadora ISCIII
Programa Programa Estatal de Fomento de la Investigación Científica y Técnica de Excelencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de Investigación en Salud
Año convocatoria 2018
Plan Estatal 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario INSTITUTO DE INVESTIGACIONES BIOMEDICAS AUGUST PI I SUNYER (IDIBAPS)
Centro realización INSTITUTO DE INVESTIGACIONES BIOMEDICAS AUGUST PI I SUNYER (IDIBAPS)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Emotional intelligence, a comparison between patients after first episode mania and those suffering from chronic bipolar disorder type I

  • Varo, Cristina|||0000-0002-8859-3052
  • Amoretti, Silvia|||0000-0001-6017-2734
  • Sparacino, Giulio
  • Jiménez, Esther
  • Solé, Brisa|||0000-0003-1673-8248
  • Bonnin, Caterina del Mar|||0000-0002-1197-1596
  • Montejo, Laura|||0000-0003-4407-9454
  • Serra-Navarro, Maria|||0000-0002-9736-4630
  • Torrent, Carla|||0000-0003-0335-582X
  • Salagre, Estela|||0000-0001-6352-5179
  • Benabarre, Antoni|||0000-0001-8814-2246
  • Salgado-Pineda, Pilar|||0000-0001-7720-0885
  • Montoro Salvatierra, Irene
  • Sáiz, Pilar A.|||0000-0002-5705-4523
  • García-Portilla, María Paz|||0000-0003-3643-1622
  • Sánchez Gistau, Vanessa|||0000-0002-8635-7144
  • Pomarol-Clotet, Edith|||0000-0002-8159-8563
  • Ramos-Quiroga, Josep Antoni|||0000-0003-1622-0350
  • Pacchiarotti, Isabella|||0000-0002-7822-0367
  • Garcia Rizo, Clemente|||0000-0002-4855-1608
  • Undurraga, Juan|||0000-0001-6958-2369
  • Reinares, María|||0000-0001-8859-4453
  • Martínez-Àran, Anabel|||0000-0002-0623-6263
  • Vieta, Eduard|||0000-0002-0548-0053
  • Verdolini, Norma|||0000-0001-9488-2881
Deficits in emotional intelligence (EI) were detected in patients with bipolar disorder (BD), but little is known about whether these deficits are already present in patients after presenting a first episode mania (FEM). We sought (i) to compare EI in patients after a FEM, chronic BD and healthy controls (HC); (ii) to examine the effect exerted on EI by socio-demographic, clinical and neurocognitive variables in FEM patients. The Emotional Intelligence Quotient (EIQ) was calculated with the Mayer-Salovey-Caruso Emotional Intelligence Test (MSCEIT). Performance on MSCEIT was compared among the three groups using generalized linear models. In patients after a FEM, the influence of socio-demographic, clinical and neurocognitive variables on the EIQ was examined using a linear regression model. In total, 184 subjects were included (FEM n = 48, euthymic chronic BD type I n = 75, HC n = 61). BD patients performed significantly worse than HC on the EIQ [mean difference (MD) = 10.09, standard error ( = 3.14, p = 0.004] and on the understanding emotions branch (MD = 7.46, = 2.53, p = 0.010). FEM patients did not differ from HC and BD on other measures of MSCEIT. In patients after a FEM, EIQ was positively associated with female sex (β = -0.293, p = 0.034) and verbal memory performance (β = 0.374, p = 0.008). FEM patients performed worse than HC but better than BD on few neurocognitive domains. Patients after a FEM showed preserved EI, while patients in later stages of BD presented lower EIQ, suggesting that impairments in EI might result from the burden of disease and neurocognitive decline, associated with the chronicity of the illness.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Sex differences in psychosocial functioning and neurocognition in bipolar disorder, a systematic review and meta-analysis

  • Serra-Navarro, Maria|||0000-0002-9736-4630
  • Clougher, Derek|||0000-0001-7631-3845
  • Oliva, Vincenzo|||0000-0002-5961-6032
  • Valenzuela-Pascual, Clàudia
  • De Prisco, Michele|||0000-0002-2032-1181
  • Forte, Maria Florencia|||0000-0001-5930-5501
  • Garriga, Marina|||0000-0001-7312-4969
  • Solé, Brisa|||0000-0003-1673-8248
  • Sánchez-Moreno, Jose|||0000-0003-1520-093X
  • Verdolini, Norma|||0000-0001-9488-2881
  • Tortorella, Alfonso|||0000-0002-8095-2305
  • Bernardo, Miquel|||0000-0001-8748-6717
  • Ramos-Quiroga, Josep Antoni|||0000-0003-1622-0350
  • Martínez-Àran, Anabel|||0000-0002-0623-6263
  • Vieta, Eduard|||0000-0002-0548-0053
  • Amoretti, Silvia|||0000-0001-6017-2734
  • Torrent, Carla|||0000-0003-0335-582X
Impairment in both psychosocial functioning and neurocognition (NC) performance is present in bipolar disorder (BD) yet the role of sex differences in these deficits remains unclear. The present systematic review and meta-analysis examined whether males and females with BD demonstrate differences in psychosocial functioning and NC performance. The Cochrane Library, EMBASE, PsycINFO, PubMed, Scopus, and Web of Science databases were systematically searched from inception until November 20, 2023. Twenty studies published between 2005 and 2023 with a total sample size of 2286 patients with BD were included. A random effects meta-analysis revealed a statistically significant result with a small effect (SMD = 0.313) for sex differences in verbal learning and memory as well as visual learning and memory (SMD = 0.263). Females outperformed males in both domains. No significant sex differences were observed for any other NC outcome or psychosocial functioning. High heterogeneity and differences in assessment scales used should be considered when interpreting these findings, given their potential impact on results. Future research should adopt a more homogenous, standardized approach using longitudinal designs to gain a clearer insight into sex differences in this population. This approach so may increase the use of preventative therapeutic options to address the difficult clinical challenge of reaching cognitive and functional recovery.